APC	Antigen presenting cells
APM	Antigen presenting machinery
β2M	β-2 microglobulin
CAR-T	Chimeric antigen receptor T (cell)
CIITA	MHC class II transactivator
CTL	Cytotoxic T cell
DC	Dendritic cells
DNMTi	DNA methyltransferase inhibitors
EGF	Epidermal growth factor
EGFR	Epidermal growth factor receptor
EMT	Epithelial-mesenchymal transition
EMT-TFs	Epithelial-mesenchymal transition transcription factors
EOC	Epithelial ovarian cancer
HGSC	High-grade serous ovarian cancer
HDACi	histone deacetylase inhibitors
HLA	Human leukocyte antigens
HRD	Homologous recombination deficiency
HSDL1	Hydroxysteroid dehydrogenase–like protein 1
Ig	Immunoglobulin
ILT2	Immunoglobulin-like transcript 2
IFN-γ	Type II interferon
IRF-1	Interferon regulatory factor
KIR3DL2	KIR three Ig domains and long cytoplasmic tail 2
KIR3DS1	KIR three Ig domains and short cytoplasmic tail 1
KIR3DS4	KIR three Ig domains and long cytoplasmic tail 4
LSK1	lysine-specific histone demethylase 1
MHC I	Major histocompatibility complex I
NCT	National clinical trial
NK	Natural killer
NLRC5	NOD-like receptor family caspase recruitment domain–containing 5
pMHC I	peptide-MHC I complex
sHLA	Soluble HLA
scFv	single-chain variable fragment
PFS	Progression-free survival
TAA	Tumor associated antigen
TAP	Transporter associated with antigen presentation
TCR	T cell receptors
TGF β1	Transforming growth factor beta 1
TGFβR	TGF β receptors
TMB	Tumor mutational burden
TME	Tumor microenvironment
TNFα	Tumor necrosis factor alpha
TAG72	Tumor-associated glycoprotein 72